Treatment of asthenic syndrome in chronic brain ischemia: TRIUMPH observational programme
A. I. Fedin, E. Yu. Solovyeva, O. P. Mironova, A. V. Fedotova · 2014 · Zh Nevrol Psikhiatr Im S S Korsakova. 114(12):104–111
What does this source report?
The observational programme reported improved asthenia scores. Treatment duration was selected by physicians, not randomly assigned.
- Population and setting
- 2,029 participants; 1,170 analyzed; 859 excluded for protocol completion/documentation problems
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian unless otherwise indicated
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Large exclusion from analysis creates potential selection bias.
- No untreated control; within-person improvement cannot establish causation.
- This programme is not a randomized trial and cannot establish long-term safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Publisher HTML article
Review depth: Methods and analysis-population narrative
Source access and review scope
Publisher methods and analysis-population passage checked.
Recorded source-check date: 2026-10-02. This date does not imply a completed systematic review.
Cite and trace this record
Original source: A. I. Fedin, E. Yu. Solovyeva, O. P. Mironova, A. V. Fedotova. Treatment of asthenic syndrome in chronic brain ischemia: TRIUMPH observational programme Zh Nevrol Psikhiatr Im S S Korsakova. 114(12):104–111 2014.
Molekul research summary: https://molekul.io/research/phenotropil-triumph-2014. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry